Poster Paper:
Financial Security and Adolescent Adherence to Antiretroviral Therapy in Uganda: Policy Implications from a Randomized Trial
*Names in bold indicate Presenter
Using a two-arm group randomized trial method, 39 participating clinics were randomly assigned to either the intervention or the control group. Adolescents in the control arm received a BSOC which included clinical care and psychosocial support complemented by six information sessions on ART adherence. Adolescents in the intervention group received the BSOC as well as a 1:1 matched Child Savings Account (CSA), withdrawals conditional upon use towards secondary education or microenterprise development. As part of the CSA package, the intervention arm also received financial literacy trainings, mentorship, and life-skills workshops.
The primary outcome of analysis was adherence to ART as measured by HIV RNA viral load. Cluster-adjusted comparisons of means and proportions were used to descriptively analyze changes in adherence between study arms while multi-level modelling was used to estimate treatment efficacy after adjusting for fixed and random effects. Analysis of pre-intervention viral load data demonstrated no statistically significant difference between study arms in regard to the proportion of participants with suppressed viral load (+6.3, p=0.182). At 24-months post intervention initiation, the proportion of virally suppressed participants in the intervention cohort increased tenfold (ΔT2-T0=+10.0, p=0.001) relative to the control group (ΔT2-T0=+1.1, p=0.733). In adjusted mixed models, simple main effects tests identified significantly lower odds of intervention adolescents having a detectable viral load at both 12- and 24-months.
These findings suggest that interventions addressing financial insecurity may be beneficial to increase ART uptake. This supports prior research demonstrating the ability of economic initiatives to improve ART adherence and extends this evidence base to an adolescent population. Such results prompt important policy questions when aiming to address the public health challenge of HIV, necessitating a dialogue on the intersections of financial security and HIV prevention and treatment.